R&D Bringing therapies to patients quicker with integrated CDMO ... Biotechs and pharmaceutical companies can receive enormous value from a trusted partnership with an integrated CDMO and CRO.
R&D Seamless scale-up: Integrated manufacturing becomes the biop... Today, the demand for speed, quality, and scalability is pushing the industry towards a different model: integrated manufacturing.
Partner Content Partner Content Trio of Senior Hires Joins Syneos Health Global Communicatio... Strengthened Communications Leadership Team to Enhance Integrated Communications Solutions for Customers in the UK and Across Europe
Partner Content Partner Content INC Research/inVentiv Health Becomes Syneos Health New Identity Signifies Industry’s Only Fully Integrated, End-to-End Biopharmaceutical Solutions Organization
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.